Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Breast Care (Basel, Switzerland)
|
February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy
Manfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Scientific Reports
|
November 17, 2018
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
Gabriele Schricker, Rudolf Napieralski, Aurelia Noske, et al.
Anticancer Research
|
April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes
Sherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 9, 2021
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)
Amanda Tufman, Jens Neumann, Farkhad Manapov, et al.
Journal of Immunology Research
|
June 23, 2017
Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting <i>Helicobacter pylori</i> Strain and Eradication Status
Luca Formichella, Laura Romberg, Hannelore Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2020
Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study
Philipp Solbach, Patrick Chhatwal, Sabrina Woltemate, et al.
Respiratory Research
|
April 24, 2021
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic
Jochen Schneider, Hrvoje Mijočević, Kurt Ulm, et al.
Frontiers in Cellular and Infection Microbiology
|
July 5, 2018
Association Between Gut Microbiota and <i>Helicobacter pylori</i>-Related Gastric Lesions in a High-Risk Population of Gastric Cancer
Juan-Juan Gao, Yang Zhang, Markus Gerhard, et al.
Gut
|
December 21, 2019
Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer
Yang Guo, Yang Zhang, Markus Gerhard, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Breast Care (Basel, Switzerland)
|
February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy
Manfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study
Katja Ott, Ken Herrmann, Florian Lordick, et al.
Scientific Reports
|
November 17, 2018
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
Gabriele Schricker, Rudolf Napieralski, Aurelia Noske, et al.
Anticancer Research
|
April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes
Sherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 9, 2021
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)
Amanda Tufman, Jens Neumann, Farkhad Manapov, et al.
Journal of Immunology Research
|
June 23, 2017
Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting <i>Helicobacter pylori</i> Strain and Eradication Status
Luca Formichella, Laura Romberg, Hannelore Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2020
Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study
Philipp Solbach, Patrick Chhatwal, Sabrina Woltemate, et al.
Respiratory Research
|
April 24, 2021
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic
Jochen Schneider, Hrvoje Mijočević, Kurt Ulm, et al.
Frontiers in Cellular and Infection Microbiology
|
July 5, 2018
Association Between Gut Microbiota and <i>Helicobacter pylori</i>-Related Gastric Lesions in a High-Risk Population of Gastric Cancer
Juan-Juan Gao, Yang Zhang, Markus Gerhard, et al.
Gut
|
December 21, 2019
Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer
Yang Guo, Yang Zhang, Markus Gerhard, et al.
Page
of 10